Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Kaye

Showing results (181-190 of 740) with videos related to

Pageof 74
Sort By:
Hospital Practice (1995)|May 10, 2015
Ceftaroline fosamil for the treatment of hospital-acquired pneumonia and ventilator-associated pneumoniaKeith S Kaye, George Udeani, Phillip Cole, et al.
Infection Control and Hospital Epidemiology|May 4, 2005
The case-case-control study design: addressing the limitations of risk factor studies for antimicrobial resistanceKeith S Kaye, Anthony D Harris, Matthew Samore, et al.
Angiology|January 1, 1982
Comparative study of the echocardiographic findings in hypertensive and nonhypertensive cardiomyopathyA Agatston, S Rubler, T Abenavoli, et al.
Journal of Virological Methods|February 1, 1993
HIV-1 plasma viraemia quantification: a non-culture measurement needed for therapeutic trialsM G Semple, S Kaye, C Loveday, et al.
Open Forum Infectious Diseases|July 29, 2021
Deferring Amputation in Diabetic Foot Osteomyelitis: Doing More Harm Than Good?Shiwei Zhou, Brian M Schmidt, Oryan Henig, et al.
The American Journal of the Medical Sciences|November 27, 2002
Utility of pulse oximetry in diagnosing pneumonia in nursing home residentsKeith S Kaye, Malini Stalam, Wendy E Shershen, et al.
Antimicrobial Agents and Chemotherapy|March 18, 2000
Risk factors for recovery of ampicillin-sulbactam-resistant Escherichia coli in hospitalized patientsK S Kaye, A D Harris, H Gold, et al.
Current Biology : CB|January 13, 2006
Spliced leader trans-splicingNicholas A Stover, Michelle S Kaye, Andre R O Cavalcanti
The British Journal of Ophthalmology|September 21, 2004
Modification of classification of ocular chemical injuriesS Harun, S Srinivasan, K Hollingworth, et al.
Antimicrobial Agents and Chemotherapy|August 22, 2025
New Perspectives on Antimicrobial Agents: Sulbactam-durlobactamJason M Pogue, Jeffrey Harrington, Walaiporn Wangchinda, et al.
Pageof 74

Showing results (181-190 of 740) with videos related to

Sort By:
Pageof 74
Hospital Practice (1995)|May 10, 2015
Ceftaroline fosamil for the treatment of hospital-acquired pneumonia and ventilator-associated pneumoniaKeith S Kaye, George Udeani, Phillip Cole, et al.
Infection Control and Hospital Epidemiology|May 4, 2005
The case-case-control study design: addressing the limitations of risk factor studies for antimicrobial resistanceKeith S Kaye, Anthony D Harris, Matthew Samore, et al.
Angiology|January 1, 1982
Comparative study of the echocardiographic findings in hypertensive and nonhypertensive cardiomyopathyA Agatston, S Rubler, T Abenavoli, et al.
Journal of Virological Methods|February 1, 1993
HIV-1 plasma viraemia quantification: a non-culture measurement needed for therapeutic trialsM G Semple, S Kaye, C Loveday, et al.
Open Forum Infectious Diseases|July 29, 2021
Deferring Amputation in Diabetic Foot Osteomyelitis: Doing More Harm Than Good?Shiwei Zhou, Brian M Schmidt, Oryan Henig, et al.
The American Journal of the Medical Sciences|November 27, 2002
Utility of pulse oximetry in diagnosing pneumonia in nursing home residentsKeith S Kaye, Malini Stalam, Wendy E Shershen, et al.
Antimicrobial Agents and Chemotherapy|March 18, 2000
Risk factors for recovery of ampicillin-sulbactam-resistant Escherichia coli in hospitalized patientsK S Kaye, A D Harris, H Gold, et al.
Current Biology : CB|January 13, 2006
Spliced leader trans-splicingNicholas A Stover, Michelle S Kaye, Andre R O Cavalcanti
The British Journal of Ophthalmology|September 21, 2004
Modification of classification of ocular chemical injuriesS Harun, S Srinivasan, K Hollingworth, et al.
Antimicrobial Agents and Chemotherapy|August 22, 2025
New Perspectives on Antimicrobial Agents: Sulbactam-durlobactamJason M Pogue, Jeffrey Harrington, Walaiporn Wangchinda, et al.
Pageof 74